Clinical Trials Browser

Interleukin-11 × Clear all

NCT06759636 2025-01-06

FRIENDS-01：A Multicenter Open-label Randomized Controlled Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Phase 3 Not yet recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

NCT05909293 2023-06-18

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05688306 2023-01-18

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT01663441 2020-09-16

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Phase 3 Completed

Classical hematology

Thrombocytopenia

NCT03720340 2020-08-11

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Phase 3 Unknown

Nasopharyngeal Carcinoma

NCT00012298 2018-08-09

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1/2 Terminated

81 enrolled 16 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00493181 2012-02-20

Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients

Phase 2 Completed

8 enrolled 3 charts

Classical hematologyMyeloidOther hematologic neoplasm

Leukemia, Thrombocytopenia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive